Vincerx Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vincerx Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2020 to Q2 2024.
  • Vincerx Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2024 was 29.7M shares, a 38.8% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 29.7M +8.29M +38.8% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 21.4M +168K +0.79% Mar 26, 2024 10-K 2024-03-29
Q3 2023 21.4M +191K +0.9% Oct 31, 2023 10-Q 2023-11-14
Q2 2023 21.4M +191K +0.9% Jul 31, 2023 10-Q 2023-08-07
Q1 2023 21.2M +188K +0.89% Mar 28, 2023 10-K 2023-03-28
Q3 2022 21.2M +169K +0.8% Oct 31, 2022 10-Q 2022-11-10
Q2 2022 21.2M +3.67M +20.9% Jul 31, 2022 10-Q 2022-08-11
Q1 2022 21.1M +3.54M +20.2% Mar 28, 2022 10-K 2022-03-29
Q3 2021 21M +12.8M +156% Oct 31, 2021 10-Q 2021-11-12
Q2 2021 17.5M Jul 31, 2021 10-Q 2021-08-12
Q1 2021 17.5M +9.32M +114% May 7, 2021 10-Q 2021-05-17
Q3 2020 8.2M Sep 23, 2020 10-K 2020-09-23
Q1 2020 8.2M May 8, 2020 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.